# Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery

> **NCT07178639** · NA · RECRUITING · sponsor: **Nemocnice Kolín** · enrollment: 150 (estimated)

## Conditions studied

- Macular Oedema
- Cataract Surgery
- NSAID (Non-Steroidal Anti-Inflammatory Drug)

## Interventions

- **DRUG:** Bromfenac 0.09 % Ophthalmic Solution
- **DRUG:** Nepafenac 0.3% Oph Susp
- **DRUG:** diclofenac 0.1% ophthalmic susp.

## Key facts

- **NCT ID:** NCT07178639
- **Lead sponsor:** Nemocnice Kolín
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07178639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07178639, "Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT07178639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*